News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Fumiko Ladd Chino: Toxicity in phase III oncology clinical trials is often incompletely reported
Fumiko Ladd Chino/bumpintheroad.us
Apr 6, 2025, 12:55

Fumiko Ladd Chino: Toxicity in phase III oncology clinical trials is often incompletely reported

Fumiko Ladd Chino, Radiation Oncologist at MD Anderson Cancer Center, shared an article by Avital M. Miller et al on X:

“Toxicity in phase III oncology clinical trials is often incompletely reported and is frequently minimized in its interpretation.

Only 1/3 reported Grade 1 to 2 toxicities and toxicity-minimizing language was used in 46% (subjectively downplay the harm of drugs).”

Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials

Authors: Avital M. Miller et al

Fumiko Ladd Chino: Toxicity in phase III oncology clinical trials is often incompletely reported

Adina H Passy Alexander D. Sherry Avital M Miller cancer Esther J Beck Ethan B Ludmir Fumiko Ladd Chino Gabrielle S Kupferman Joseph Abi Jaoude OncoDaily Oncology Pavlos Msaouel Ramez Kouzy Timothy A Lin
Special Coverage
Blog Posts
Aug 18, 2025, 19:28
Liz O’Riordan: Everything You Need to Know about Breast Cancer Recurrence
Blog Posts
Aug 18, 2025, 19:17
Matteo Bauckneht: Pitfalls in PSMA-Based RLT - A Case-Based Review at EANM25
Insight
Aug 18, 2025, 18:55
NCODA Brings the BREAKWATER Trial into Practice
Blog Posts
Aug 18, 2025, 18:20
Amol Akhade: Key Late-Breaking and Practice-Changing Trials to Watch at WCLC 2025
Insight
Aug 18, 2025, 18:09
Hung Trinh Highlights Pasritamig, a First-in-Class T-Cell Engager for Prostate Cancer
Voices
Aug 18, 2025, 17:43
Building a Healthier Future for Women Also Means Building a Healthier Future for the Next Generation - Elekta Foundation
Voices
Aug 18, 2025, 17:35
Mandar Muzumdar: The Evolution of Single-Cell 3D Genomes in KRAS-Driven Cancers
Blog Posts
Aug 18, 2025, 17:21
Douglas Flora: Create the Things You Wish Existed
Blog Posts
Aug 18, 2025, 17:13
Matt Yurgelun: Thrilled to Be Joining The Jimmy Fund Radio-Telethon
Voices
Aug 18, 2025, 17:04
Striking out Cancer for Patients Like Charlie - The Jimmy Fund
Insight
Aug 18, 2025, 16:52
Darren Haywood: Pleased to Receive COSA Endorsement of the MASCC COG-IMPACT Tool
Science
Aug 18, 2025, 16:48
Petros Grivas: Highlighting Intra-Patient Tumor Heterogeneity in Prostate Cancer Research